Completed PHASE2 INTERVENTIONAL 2-arm NCT01483833

Efficacy Study of Iferanserin to Treat Hemorrhoids

Protocol for the Study of the Effects of S-MPEC (Iferanserin) in Patients With Hemorrhoids

Sponsor: Ventrus Biosciences, Inc

Updated 5 times since 2017 Last updated: Aug 19, 2013 Started: Sep 30, 2001 Primary completion: Aug 31, 2002 Completion: Aug 31, 2002

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Hemorrhoids and is currently completed. Ventrus Biosciences, Inc leads this study, which shows 5 recorded versions since 2001 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Sep 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ventrus Biosciences, Inc

Data source: Ventrus Biosciences, Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mannheim, Germany